Targeted clinical focus Courtagen specializes in pediatric neurological disorders such as mitochondrial disease, epilepsy, and autism spectrum disorder, offering genetic testing to inform diagnosis and treatment decisions. This suggests sales opportunities with pediatric neurology clinics, hospital systems, and therapy centers seeking actionable genomic insights for complex cases.

Fast, accessible testing The company emphasizes quick turnaround times and a painless saliva-based testing process with direct doctor delivery of reports. This can be marketed to practices needing timely, noninvasive diagnostics to accelerate care plans and patient satisfaction.

Financial accessibility Courtagen offers a Care Financial Assistance Plan with potential zero to moderate cost sharing, creating a value proposition for patients with limited insurance coverage or high out-of-pocket costs, and potential partnerships with patient advocacy groups and hospital financial offices.

Expert interpretation network Results are interpreted by a team of seasoned geneticists and a Medical Director with extensive pediatric neurology experience, which can be leveraged to position Courtagen as a trusted, specialty-grade partner for complex case consultations and second opinions.

Strategic partnerships and growth Past collaborations with industry players and acquisitions in related epilepsy and mitochondrial research indicate receptivity to partnerships and expansions. This signals opportunities for co-development, data-sharing arrangements, and expanding panel offerings with health systems and academic centers.